Identification of palmatine as an inhibitor of West Nile virus

Archives of Virology

Volumn 155, Issue 8, 2010, Pages 1325-1329

  Jia, Fan ^a,b   Zou, Gang ^a   Fan, Jingjing ^a,b   Yuan, Zhiming ^a  

^a WUHAN INSTITUTE OF VIROLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; BERBERINE DERIVATIVE; NS2B PROTEIN, FLAVIVIRUS; NS3 PROTEIN, FLAVIVIRUS; PALMATINE; RNA HELICASE; SERINE PROTEINASE; VIRUS PROTEIN;

ARTICLE; CHEMISTRY; CHINA; COPTIS; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; MEDICINAL PLANT; WEST NILE FLAVIVIRUS;

ANTIVIRAL AGENTS; BERBERINE ALKALOIDS; CHINA; COPTIS; PLANTS, MEDICINAL; RNA HELICASES; SERINE ENDOPEPTIDASES; VIRAL NONSTRUCTURAL PROTEINS; WEST NILE VIRUS;

COPTIS; COPTIS CHINENSIS; DENGUE VIRUS; FLAVIVIRUS; WEST NILE VIRUS; YELLOW FEVER VIRUS;

EID: 77955172547     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-010-0702-4     Document Type: Article

References (20)

1. Aleshin AE, Shiryaev SA, Strongin AY, Liddington RC (2007) Structural evidence for regulation and specificity of flaviviral proteases and evolution of the Flaviviridae fold. Protein Sci 16: 795-806.
2. Ekonomiuk D, Su XC, Ozawa K, Bodenreider C, Lim SP, Yin Z, Keller TH, Beer D, Patel V, Otting G, Caflisch A, Huang D (2009) Discovery of a non-peptidic inhibitor of west nile virus NS3 protease by high-throughput docking. PLoS Negl Trop Dis 3: e356.
3. Falgout B, Markoff L (1995) Evidence that flavivirus NS1-NS2A cleavage is mediated by a membrane-bound host protease in the endoplasmic reticulum. J Virol 69: 7232-7243.
4. Gorbalenya AE, Donchenko AP, Koonin EV, Blinov VM (1989) N-terminal domains of putative helicases of flavi- and pestiviruses may be serine proteases. Nucleic Acids Res 17: 3889-3897.
5. Gu B, Ouzunov S, Wang L, Mason P, Bourne N, Cuconati A, Block TM (2006) Discovery of small molecule inhibitors of West Nile virus using a high-throughput sub-genomic replicon screen. Antiviral Res 70: 39-50.
6. Hayes CG (2001) West Nile Virus: Uganda, 1937, to New York City, 1999. Ann N Y Acad Sci 951: 25-37.
7. Johnston PA, Phillips J, Shun TY, Shinde S, Lazo JS, Huryn DM, Myers MC, Ratnikov BI, Smith JW, Su Y, Dahl R, Cosford ND, Shiryaev SA, Strongin AY (2007) HTS identifies novel and specific uncompetitive inhibitors of the two-component NS2B-NS3 proteinase of West Nile virus. Assay Drug Dev Technol 5: 737-750.
8. Li H, Clum S, You S, Ebner KE, Padmanabhan R (1999) The serine protease and RNA-stimulated nucleoside triphosphatase and RNA helicase functional domains of dengue virus type 2 NS3 converge within a region of 20 amino acids. J Virol 73: 3108-3116.
9. Löhr K, Knox JE, Phong WY, Ma NL, Yin Z, Sampath A, Patel SJ, Wang WL, Chan WL, Rao KR, Wang G, Vasudevan SG, Keller TH, Lim SP (2007) Yellow fever virus NS3 protease: peptide-inhibition studies. J Gen Virol 88: 2223-2227.
10. Mueller NH, Pattabiraman N, Ansarah-Sobrinho C, Viswanathan P, Pierson TC, Padmanabhan R (2008) Identification and biochemical characterization of small-molecule inhibitors of West Nile virus serine protease by a high-throughput screen. Antimicrob Agents Chemother 52: 3385-3393.
11. Mukhopadhyay S, Kuhn RJ, Rossmann MG (2005) A structural perspective of the flavivirus life cycle. Nat Rev Microbiol 3: 13-22.
12. Noble CG, Chen YL, Dong H, Gu F, Lim SP, Schul W, Wang QY, Shi PY (2010) Strategies for development of dengue virus inhibitors. Antiviral Res 85: 450-462.
13. Noueiry AO, Olivo PD, Slomczynska U, Zhou Y, Buscher B, Geiss B, Engle M, Roth RM, Chung KM, Samuel M, Diamond MS (2007) Identification of novel small-molecule inhibitors of West Nile virus infection. J Virol 81: 11992-12004.
14. Puig-Basagoiti F, Tilgner M, Forshey BM, Philpott SM, Espina NG, Wentworth DE, Goebel SJ, Masters PS, Falgout B, Ren P, Ferguson DM, Shi PY (2006) Triaryl pyrazoline compound inhibits flavivirus RNA replication. Antimicrob Agents Chemother 50: 1320-1329.
15. Sampath A, Padmanabhan R (2009) Molecular targets for flavivirus drug discovery. Antiviral Res 81: 6-15.
16. Stadler K, Allison SL, Schalich J, Heinz FX (1997) Proteolytic activation of tick-borne encephalitis virus by furin. J Virol 71: 8475-8481.
17. Thomas G (2002) Furin at the cutting edge: From protein traffic to embryogenesis and disease. Nat Rev Mol Cell Biol 3: 753-766.
18. Tomlinson SM, Malmstrom RD, Russo A, Mueller N, Pang YP, Watowich SJ (2009) Structure-based discovery of dengue virus protease inhibitors. Antiviral Res 82: 110-114.
19. Wengler G, Wengler G (1991) The carboxy-terminal part of the NS3 protein of the West Nile flavivirus can be isolated as a soluble protein after proteolytic cleavage and represents an RNA stimulated NTPase. Virology 184: 707-715.
20. Yang JM, Chen YF, Tu YY, Yen KR, Yang YL (2007) Combinatorial computational approaches to identify tetracycline derivatives as flavivirus inhibitors. PLoS One 2: e428.